$0.133
0.0029[2.23%]
At close: Apr 26
Latest News for Zomedica Stock (AMEX:ZOM)
Zomedica Stock (AMEX: ZOM)
Categories: All
Monday, April 01, 2024
- Zomedica shares are trading higher after the company reported Q4 financial results.Benzinga Newsdesk - Apr 1, 2024, 4:37PM
- Zomedica Q4 2023 GAAP EPS $(0.02), Sales $7.337M Beat $7.000M EstimateBenzinga Newsdesk - Apr 1, 2024, 4:28PM
- Earnings Scheduled For April 1, 2024Benzinga Insights - Apr 1, 2024, 5:13AM
Wednesday, March 13, 2024
Thursday, January 18, 2024
Wednesday, January 17, 2024
Thursday, January 04, 2024
Monday, December 18, 2023
- Zomedica shares are trading higher. The company announced the commercial launch of three new assays for TRUFORMA In-Clinic Biosensor Testing PlatformBenzinga Newsdesk - Dec 18, 2023, 1:37PM
- Zomedica Expands Market Opportunity for Truforma Diagnostic Platform with Launch of Three New Assays for Commonly Performed Diagnostic Tests for Canine Gastrointestinal DiseaseBenzinga Newsdesk - Dec 18, 2023, 6:35AM
Wednesday, December 06, 2023
Monday, November 13, 2023
Thursday, October 05, 2023
Thursday, September 14, 2023
Wednesday, September 13, 2023
Thursday, August 10, 2023
Friday, May 26, 2023
Thursday, May 11, 2023
- CORRECTION: Zomedica Q1 EPS $(0.007) Down From $(0.004) YoY, Sales $5.48M Miss $6.63M EstimateHappy Mohamed - May 11, 2023, 4:57PM
- Zomedica Q1 EPS $(0.007) Down From $(0.004) YoY, Sales $5.48M Miss $6.63M EstimateHappy Mohamed - May 11, 2023, 4:48PM
- Earnings Scheduled For May 11, 2023Benzinga Insights - May 11, 2023, 9:58AM
Monday, May 08, 2023
Friday, March 17, 2023
Wednesday, March 15, 2023
Thursday, February 09, 2023
Wednesday, January 18, 2023
Tuesday, January 17, 2023
Friday, January 06, 2023
- Why Spruce Biosciences Shares Are Trading Higher By 100%? Here Are Other Stocks Moving In Friday's Mid-Day SessionLisa Levin - Jan 6, 2023, 1:16PM
- Benzinga's Top Ratings Upgrades, Downgrades For January 6, 2023Benzinga Insights - Jan 6, 2023, 10:00AM
- Zomedica shares are trading higher after Dawson James initiated coverage on the stock with a Buy rating and a $6 price target.Benzinga Newsdesk - Jan 6, 2023, 8:47AM
- Dawson James Initiates Coverage On Zomedica with Buy Rating, Announces Price Target of $6Benzinga Newsdesk - Jan 6, 2023, 8:25AM